Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer’s Disease

—Data from 479-Patient Study Confirms Strong Prognostic Utility of AlzoSure® Predict for Identifying Whether or Not Individuals Will Experience a Significant Cognitive Decline due to Alzheimer’s Disease (AD) Within a 2-Year or 6-Year Timeframe— —Ability to Identify “Rapid Progressors” Who…